Dale Thomas

Mytide Therapeutics, Inc. is a peptide and biopolymer manufacturing and computational biology company based in Massachusetts. Mytide's focus is on eliminating the time-consuming and labor-intensive chemical and screening processes that prevent innovative therapeutics from reaching the clinic. The American company's quick-turn manufacturing technology, combined with AI-enabled predictive analytics, provides access to a novel peptide space for the discovery and therapeutic manufacturing of difficult-to-make natural and non-natural peptide and peptide conjugates. The company was founded by Dale Thomas and has been led by CEO Martina Diekmann since 2023.

Mytide Therapeutics, Inc. is a peptide and biopolymer manufacturing and computational biology company based in Massachusetts. Mytide's focus is on eliminating the time-consuming and labor-intensive chemical and screening processes that prevent innovative therapeutics from reaching the clinic. The American company's quick-turn manufacturing technology, combined with AI-enabled predictive analytics, provides access to a novel peptide space for the discovery and therapeutic manufacturing of difficult-to-make natural and non-natural peptide and peptide conjugates. The company was founded by Dale Thomas and has been led by CEO Martina Diekmann since 2023.

Mytide Therapeutics, Inc. is a peptide and biopolymer manufacturing and computational biology company based in Massachusetts. Mytide's focus is on eliminating the time-consuming and labor-intensive chemical and screening processes that prevent innovative therapeutics from reaching the clinic. The American company's quick-turn manufacturing technology, combined with AI-enabled predictive analytics, provides access to a novel peptide space for the discovery and therapeutic manufacturing of difficult-to-make natural and non-natural peptide and peptide conjugates. The company was founded by Dale Thomas and has been led by CEO Martina Diekmann since 2023.